Can POC Platforms Transform the CGT Market? with Vered Caplan, CEO of Orgenesis Inc.
Spencer talks to to Vered Caplan, CEO at Orgenesis Inc. about how their Point Of Care (POC) Platform aims to shape the Cell and Gene Therapies (CGT) ecosystem and market. Click here to listen.